[Federal Register Volume 89, Number 217 (Friday, November 8, 2024)]
[Notices]
[Pages 88778-88780]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-25986]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-25-24FI]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``Comprehensive Evaluations for the Well-
Integrated Screening and Evaluation for Women Across the Nation Program 
(WISEWOMAN), The National Cardiovascular Health Program (The National 
CVH Program), and The Innovative Cardiovascular Health Program (The 
Innovative CVH Program)'' to the Office of Management and Budget (OMB) 
for review and approval. CDC previously published a ``Proposed Data 
Collection Submitted for Public Comment and Recommendations'' notice on 
5/7/2024 to obtain comments from the public and affected agencies. CDC 
did not receive comments related to the previous notice. This notice 
serves to allow an additional 30 days for public and affected agency 
comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    Comprehensive Evaluations for the Well-Integrated Screening and 
Evaluation for Women Across the Nation Program (WISEWOMAN), The 
National Cardiovascular Health Program (The National CVH Program), and 
The Innovative Cardiovascular Health Program (The Innovative CVH 
Program)--New--National Center for Chronic Disease Prevention and 
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention 
(CDC).

Background and Brief Description

    The Centers for Disease Control and Prevention (CDC) Division for 
Heart Disease and Stroke Prevention (DHDSP) are submitting this new 
three-year information collection request (ICR) for an evaluation of 
the three recently launched cooperative agreements: Well-Integrated 
Screening of Women Across the Nation (WISEWOMAN), The National 
Cardiovascular Health Program (The National CVH Program), and The 
Innovative Cardiovascular Health Program (The Innovative CVH Program). 
The WISEWOMAN program supports the early detection and treatment of 
hypertension in low-income, uninsured, and underinsured participants, 
ages 35-64. The National CVH Program implements evidence-based 
strategies to manage CVD in populations impacted by the high prevalence 
of CVD, exacerbated by health inequities and disparities, social 
determinants, such as low incomes, poor health care, and unfair 
opportunity structures, emphasizing hypertension and high cholesterol 
control among adults aged 18-85. The Innovative CVH Program focuses on 
implementing innovative evidence-based strategies assess and address 
the disparities and inequities in communities at highest risk, where 
there is a particular need for equity-focused health system 
interventions to prevent, detect, control, and manage hypertension and 
high cholesterol, specifically among populations with a crude 
hypertension prevalence rate of 53% or higher at the census tract 
level. For two of the cooperative agreements, recipients collaborate 
with public health entities, health systems, health care providers, 
community leaders, and other partners through Learning Collaboratives 
to facilitate sustainable change and improvement in cardiovascular 
health outcomes, particularly for those at the highest risk of poorer 
health outcomes. These cooperative agreements build upon CDC's previous 
work of identify promising CVD prevention and management practices and 
funding various organizations, including State and County governments, 
American Indian or Alaska Native tribal governments, non-government 
organizations, institutions of higher education, to implement evidence-
based strategies in their jurisdictions. Since the cooperative 
agreements are a substantial investment of federal funds, it is 
important to demonstrate the types of interventions being implemented 
and what is being accomplished using these funds through a 
comprehensive evaluation.
    The comprehensive evaluation of these programs includes process and 
outcome evaluations, and a cross-program analysis to assess the unique 
contributions of each program towards evidence-based strategies, health 
equity advancement, and health system transformation over the five 
program

[[Page 88779]]

years. The evaluation aims to describe the implementation of the 
programs, assess the extent to which short-term, intermediate, and 
long-term outcomes have been met, and estimate the costs involved in 
implementing the programs. The comprehensive evaluation is designed to 
complement the evaluations already being conducted by program 
recipients. The data collection focuses on obtaining qualitative and 
cost information at the organizational and community levels about 
strategy implementation, facilitators and barriers, and other 
contextual information that affects program implementation and 
participant outcomes. Data collection activities of the comprehensive 
evaluation include qualitative interviews for evaluability assessments, 
exploratory assessments, and cost data collected for a cost study. 
During the qualitative data collection, semi-structured interviews will 
be conducted with recipients, their partnering sites, and Learning 
Collaborative members, providing a multifaceted view of the program's 
implementation and outcomes. Cost data will be used to estimate the 
implementation costs and value of resources invested by program 
recipients and their partners. Cost data will be collected through an 
excel-based cost inventory tool, key informant interviews, and document 
reviews. There are no costs to respondents except their time. Data 
collection tools are crafted to ensure relevance and to capture 
essential information needed to evaluate the effectiveness and impact 
of the program strategies, while minimizing respondent burden.
    The findings from the data collection will provide tailored, 
action-oriented, and timely recommendations for program improvement 
throughout the program period. It will foster documentation and sharing 
of lessons learned, contribute to the evidence base, and support 
replication and scaling of promising program strategies. Without 
collection of evaluative data, CDC will not be able to capture critical 
information needed to continuously improve programmatic efforts and 
clearly demonstrate the use of federal funds. CDC requests OMB approval 
for 484 annual burden hours. There is no cost to respondents other than 
their time to participate.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondents                   Form name            Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
Recipients............................  Evaluability Assessment               24               1             0.5
                                         Nomination
                                         Form_NCHP_ICHP.
                                        Evaluability Assessment               12               1             0.5
                                         Nomination Form_WW.
                                        Eval Assessment CQM                    6               1             1.5
                                         Recipient Interview
                                         Guide NCHP_ICHP.
                                        Eval Assessment CQM                    3               1             1.5
                                         Recipient Interview
                                         Guide WW.
                                        Eval Assessment TBC                    6               1             1.5
                                         Recipient Interview
                                         Guide NCHP_ICHP.
                                        Eval Assessment TBC                    3               1             1.5
                                         Recipient Interview
                                         Guide WW.
                                        Eval Assessment CCL                    3               1             1.5
                                         Recipient Interview
                                         Guide NCHP_ICHP.
                                        Eval Assessment CCL                    3               1             1.5
                                         Recipient Interview
                                         Guide WW.
                                        Ex Assessment CQM                      3               1             1.5
                                         Recipient Interview
                                         Guide NCHP_ICHP.
                                        Ex Assessment CQM                      2               1             1.5
                                         Recipient Interview
                                         Guide_WW.
                                        Ex Assessment TBC                      3               1             1.5
                                         Recipient Interview
                                         Guide NCHP_ICHP.
                                        Ex Assessment TBC                      2               1             1.5
                                         Recipient Partner
                                         Interview Guide_WW.
                                        Ex Assessment CCL                      3               1             1.5
                                         Recipient Interview
                                         Guide NCHP_ICHP.
                                        Ex Assessment CCL                      2               1             1.5
                                         Recipient Interview
                                         Guide_WW.
                                        Cost Study Interview                  37               1               1
                                         Guide_Recipient.
                                        Comprehensive Evaluation              37               1             2.5
                                         Resource Use and Cost
                                         Inventory
                                         Tool_Recipient.
Partners..............................  Eval Assessment CQM                    6               1             1.5
                                         Partner Interview Guide
                                         NCHP_ICHP.
                                        Eval Assessment CQM                    3               1             1.5
                                         Partner Interview Guide
                                         WW.
                                        Eval Assessment TBC                    6               1             1.5
                                         Partner Interview Guide
                                         NCHP_ICHP.
                                        Eval Assessment TBC                    3               1             1.5
                                         Partner Interview Guide
                                         WW.
                                        Eval Assessment CCL                    6               1             1.5
                                         Partner Interview Guide
                                         NCHP_ICHP.
                                        Eval Assessment CCL                    3               1             1.5
                                         Partner Interview Guide
                                         WW.
                                        Ex Assessment CQM                      3               1             1.5
                                         Partner Interview Guide
                                         NCHP_ICHP.
                                        Ex Assessment CQM                      1               1             1.5
                                         Partner Interview
                                         Guide_WW.
                                        Ex Assessment CCL                      3               1             1.5
                                         Partner Interview Guide
                                         NCHP_ICHP.
                                        Ex Assessment CCL                      1               1             1.5
                                         Partner Interview
                                         Guide_WW.
                                        Ex Assessment TBC                      3               1             1.5
                                         Partner Interview Guide
                                         NCHP_ICHP.
                                        Ex Assessment TBC                      1               1             1.5
                                         Partner Interview
                                         Guide_WW.
                                        Cost Study Interview                  55               1               1
                                         Guide_Partner.
                                        Comprehensive Evaluation              55               1             2.5
                                         Resource Use and Cost
                                         Inventory Tool_Partner.
Learning Collaborative................  Eval Assessment LC                    12               1               1
                                         Interview Guide NCHP
                                         ICHP.
                                        Ex Assessment LC                       6               1               1
                                         Interview Guide
                                         NCHP_ICHP.
----------------------------------------------------------------------------------------------------------------



[[Page 88780]]

Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2024-25986 Filed 11-7-24; 8:45 am]
BILLING CODE 4163-18-P